13 Results

People

  1. Matasar
    Matasar
  2. Zelenetz
    Zelenetz
  3. Hamlin
    Hamlin
  4. Moskowitz
    Moskowitz
  5. Noy
    Noy
  6. Sauter
    Sauter
  7. Gerecitano
    Gerecitano
  8. Kumar
    Kumar
  9. Palomba
    Palomba
  10. Perales
    Perales

Groups

  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Hematologic Malignancies, Division of (13)
  4. Lymphoma (13)
  5. Survivorship Research (13)
  6. Bone Marrow Transplant (6)
  7. Population Sciences Research Program (5)
  8. Epidemiology and Biostatistics (4)
  9. Biostatistics Service (3)
  10. Molecular Imaging and Therapy Service (3)
  1. "cyclophosphamide"
  2. "Matthew Matasar"
Formats
  1. Journal Article (13)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Hematologic Malignancies, Division of (13)
  4. Lymphoma (13)
  5. Survivorship Research (13)
  6. Bone Marrow Transplant (6)

More Groups

People
  1. Matthew Matasar (13)
  2. Andrew Zelenetz (7)
  3. Craig Moskowitz (6)
  4. Paul Hamlin (6)
  5. Ariela Noy (5)
  6. Craig Sauter (5)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2015 (5)
  5. 2014 (1)
  6. 2012 (1)

More Years

Publications
  1. Blood (2)
  2. Leukemia and Lymphoma (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood Advances (1)
  5. British Journal of Haematology (1)
  6. Clinical Lymphoma, Myeloma and Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (3)
  3. Taylor & Francis Group (2)
  4. Elsevier Science, Inc. (1)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Patient preferences for first-line treatment of classical Hodgkin lymphoma: A US survey and discrete choice experiment
    Journal Article

    Khan, N.; Feliciano, J.; Müller, K.; He, M.; Tao, R.; Korol, E.; Dalal, M.; Rebeira, M.; Matasar, M.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Imaging for staging and response assessment in lymphoma
    Journal Article

    Johnson, S. A.; Kumar, A.; Matasar, M. J.; Schöder, H.; Rademaker, J.
    Radiology (2015)

    Fulltext@MSK | Save
  • Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
    Journal Article

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Faivre, G.; Weaver, S. A.; Moskowitz, C. H.; Omuro, A. M.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
    Journal Article

    Omuro, A.; Correa, D. D.; Deangelis, L. M.; Moskowitz, C. H.; Matasar, M. J.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
    Journal Article

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save